INTRODUCTION
The recent discoveries of multiple SNPs across the genome as common, reproducible genetic risk factors for prostate cancer (PC) have been impressive. Over 30 common sequence variants have now been confirmed to be associated with PC risk, emphasizing the polygenic nature of inherited susceptibility for this disease [1] . In spite of the substantial progress in this area, current estimates suggest that the identified loci do not explain the majority of the excess risk associated with PC family history [1] , one of the most reproducible risk factors for PC [2, 3] .
Attempts to map PC susceptibility genes by linkage analysis of individual family collections have yielded few reproducible leads despite numerous genomewide scans, most likely due to genetic and disease heterogeneity [4] [5] [6] . In an effort to address this question more effectively, we previously carried out a large linkage study that included 1,233 PC families collected by members of the International Consortium for Prostate Cancer Genetics (ICPCG) [7] . This study provided strong evidence that one or a few major genes cannot account for the majority of disease in PC families. At the same time, a number of loci demonstrated suggestive linkage signals, consistent with a complex genetic etiology for this disease. To extend these studies using a higher resolution marker set, and to assess which of these linkage signals might warrant additional investigation, in this report we describe a second combined linkage analysis with 6,000 SNPs to interrogate an independent set of 762 families collected by the ICPCG. Table I summarizes the characteristics of the 762 PC families from the 11 ICPCG groups participating in this analysis. Fifty-three percent of families had a mean age at diagnosis of <65 years, and 21% had four or more affected family members. Most of the families (65%) were collected in Europe or Australia, with the remainder collected in the US. The current analysis was restricted to Caucasian families; analysis of linkage results from African American pedigrees collected by members of the ICPCG will be described in a separate report. Figure 1 and Table II are the linkage results for the entire set of 762 families using dominant (dom), recessive (rec), and nonparametric (KCLOD or asm) linkage models. The strongest evidence of linkage in the complete set of families is located in a broad region with multiple peaks on the proximal and mid-q arm of chromosome 4. A maximum HLOD ¼ 2.62 was observed under a recessive model at 4q22 at 97 cM, along with several other peaks over 1.86 between 74 and 115 cM, 4q13-25. An examination of LOD scores by individual family collection indicates that six of the seven largest family collections had scores over 0.9 in the 12 cM interval between 83 and 102 cM on this chromosome, using either a recessive or asm model (Table III) .
RESULTS

Study Population: 762 Prostate Cancer Families
SNP Scan Linkage Results
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Linkage Signals in Subsets of Families
Comparison of Two Linkage Scans in ICPCG Families
To search for reproducible linkage signals, we compared the results of this SNP linkage scan (designated here SNP scan) with our previous scan of 1,233 families using microsatellite markers (MS scan) [7] . Of the six regions of suggestive linkage found in the MS scan, none were supported by LOD scores reaching the threshold for suggestive linkage, that is, 1.86, in the SNP scan. However, more modest evidence of replication was observed on the proximal short arm of chromosome 8. In the SNP scan, an HLOD of 1.63 was observed at 8p11 (59 cM) under a dominant model. In the MS scan, two signals were observed on 8p, one at 60 cM (1.94) and one at 46 cM (1.97), under recessive and dominant models, respectively. For the remaining four regions of suggestive linkage found in our first scan, at 5q12, 15q11, 17q21, and 22q12, little or no evidence for linkage was seen in the SNP scan (LOD scores < 0.4).
Similarly, for all regions reaching LOD scores of 1.5 or greater in the complete set of families analyzed in the SNP scan, including the multiple loci on chromosomes 2 and 4, 8p11, 11p15, 12q23, 16q21, and 18q11, the highest score observed in the MS scan was 0.53 at 133 cM on chromosome 2.
Comparison of Two Linkage Scans in Subsets of Families
In families with a young age at diagnosis, dom HLOD scores 1.86 were observed on 3p in both scans, although the peak locations differed by over 20 cM (35 cM in SNP scan and 57 cM in MS scan). When comparing regions of linkage in the scans of families with five or more affected members, peaks over 1.86 were observed within 15 cM of each other on 16p12 (at 34 cM in MS scan and 49 cM in SNP scan) (asm LOD 2.04 and 2.14, respectively).
Of the three regions reaching suggestive linkage (6p22, 11q14, and 20q11) in our previous MS scan of families with aggressive disease, one region, 11q14 provided some evidence of an overlapping signal in the SNP scan with a rec HLOD score of 0.8 at 100 cM. Also in this group of families, coinciding linkage signals occurred at 8q24, where dom HLOD scores of 1.17 and 3.05 were observed in the same positions (137 cM) in the MS and SNP scans, respectively.
DISCUSSION
In this report, we describe a genome-wide linkage study of 762 families collected by members of the ICPCG. This is the second largest collection of PC The Prostate Of the six regions of suggestive linkage observed in the previous MS scan of 1,233 PC families [7] , one region, 8p11, attained a LOD score over 1.5 in the present SNP scan. In addition, overlapping linkage signals in the two scans provided some evidence of replication in defined subsets of families analyzed.
The Prostate Both families with young age at diagnosis and families with five or more affected individuals had moderate linkage signals at 3p24 and 16p12, respectively, in both scans. In addition, the subset of families with clinically aggressive disease showed linkage to 8q24 in both scans. Thus, while overall replication of previous linkage peaks was quite limited, several loci, particularly on chromosome 8, showed consistent linkage signals in two large, independent collections of PC families. Chromosome 8 has long been suggested to harbor both prostate tumor suppressor gene(s) and oncogene(s) due to the frequent copy number alterations (deletions of 8p and gains of 8q, respectively) occurring somatically in specimens of prostate tumor tissue [8] [9] [10] , reviewed in [11, 12] . At the germline level, linkage at 8p has been observed in PC family collections from Japan, Sweden, Germany, and the US [13] [14] [15] [16] [17] , although in majority of these studies the signals observed were more telomeric than the one observed here. In addition, a large case-control study conducted by PRACTICAL found two SNPs at 8p21, near NKX3.1, to be associated with PC risk [18] .
The 8q24 locus been extensively analyzed by GWAS, with five or more regions reproducibly shown to be associated with PC risk [19] [20] [21] . Associations of inherited PC risk and this region were first identified through a fine-mapping study of a linkage peak observed in a genome-wide scan of Icelandic PC families [22] . Linkage to this region was also reported by Camp et al. [23] in extended PC families from Utah. In future studies, it will be of interest to determine whether any of the susceptibility loci identified in the original study and the association studies since, contribute to the linkage signals observed here. A gene of particular interest for PC, MYC, lies in the region of linkage observed in this study in families with more aggressive disease. Previous studies have demonstrated the common up-regulation of this gene early in human prostate carcinogenesis [24] [25], amplification of the gene in advanced PC [26] [27] , and the ability of prostate-specific expression of this gene to induce PC in animal models [28] [29] . Such studies, together with recent work demonstrating interactions between risk loci and MYC regulatory elements have led to the hypothesis that the 8q24 risk alleles that have been identified to date modify PC risk mechanistically by altering MYC regulation and expression [30] [31] [32] [33] [34] .
In the complete family collection, the strongest linkage signals in this study were observed on the proximal and mid q arm of chromosome 4. One important aspect of this signal is the contributions provided by the multiple different family collections. Interestingly, six of the seven largest family collections (ranging from 35 to 174 families) had LOD scores over 0.9 in the 12 cM interval between 93 and 105 cM on this chromosome, whereas the four smaller collections (n < 25 families) contributed little evidence to this signal. Curiously, the six positive family collections include all five groups originating from Europe/ Australia, suggesting a possible geographical association to the chromosome 4 linkage, although limited sample size of the US family sets, or chance occurrence The Prostate are also possible explanations for this observation. It is of interest that recent GWAS findings have led to the identification and confirmation of several SNPs on 4q22 and 4q24, in introns of PDLIM5, and upstream of TET2, respectively, as being associated with PC risk [18] . Whether or not common risk alleles at these or nearby loci play a role in the linkage signal observed in the larger family collections studied here is a question for further investigation. Stanford et al. [35] recently reported a SNP-based linkage scan in which several linkage signals were reported to coincide with results from this study. Specifically, coincident peaks were observed at 15q13-14 and 2q14-21 in this study and the one reported here, although the signals were observed in different subsets of PC families. Evidence of linkage to the long arm of chromosome 8 (8q22) was observed in the complete set of 289 Caucasian families.
One of the aims of this study was to replicate findings from our earlier MS scan [7] ; however few loci were observed in both studies. While this is disappointing, it is not surprising given the known genetic heterogeneity of PC. Indeed, a limitation of our study is the potentially heterogeneous genetic and environmental influences arising from a collection of families from multiple locations across the US, Europe, and Australia. Over half of the families (65%) studied in this scan were collected in Europe or Australia, while the majority of families (79%) studied in our previous MS scan were collected in the US. Differences in intensity of PC screening in Europe versus the US may lead to substantial differences in the distribution of disease stage at diagnosis (e.g., lower stage due to widespread PSA testing in the US). While we have attempted to address some of these differences by examining specific subsets of PC families stratified by age at diagnosis and clinical and pathologic variables of the disease, this may not be sufficient to account for the heterogeneity that may be introduced by the differences in clinical practices between the continents.
It should be noted that with respect to comparability with our previous MS scan, while in general the family characteristics were quite similar, the families in this scan had on average fewer members affected with PC The Prostate 
This fact could have implications with respect to the linkage evidence on 8q24. Smaller numbers of affected individuals within families could reflect a greater presence of sporadic disease. While little is known about the role of 8q24 susceptibility variants in familial PC, there is unequivocal evidence that these risk alleles are associated with sporadic PC even though the relative risks associated with these risk alleles are small to modest. It is interesting to note that the Icelandic families in which the 8q24 locus was originally identified through linkage analysis were of similar average size to the families in this study [22] .
The strengths of this study are its large size and increased genetic information and resolution due to the use of dense SNP panels for genotyping. While the wide area of family ascertainment may generate heterogeneity, the large number of families afforded by this approach increases power and possibly results in the identification of more robust genetic signals. Finally, the large number of families increases our ability to examine potentially more homogeneous subsets of families while still maintaining reasonable levels of power.
In summary, in an examination of results from a high resolution SNP scan of 762 families and a previous MS scan of 1,233 independent PC families, no locus emerges as an unequivocally strong candidate. However, our results suggest that a broad region on proximal 4q, and multiple regions on chromosome 8 are possible candidate regions harboring PC susceptibility loci. In light of evidence from this and previous studies, further analysis of these regions appears warranted.
METHODS
Ascertainment of Families
The ICPCG study populations have been previously described in detail [36] . Each group within the ICPCG recruited PC families and 11 ICPCG groups contributed to this combined genome-wide screen: 
Def|nition of Affected Status and Classif|cation of Pedigrees
Affected individuals were defined as men diagnosed with PC that had been confirmed by either medical records or death certificates. Self-or relativereported affected men without either medical records or death certificate confirmation were considered as The Prostate having unknown affected status. All men without a diagnosis of PC were coded as having unknown affected status, regardless of whether they had undergone screening for PC. Hence, all analyses were based on the sharing of marker genotypes among affected individuals, with no consideration of the phenotype for the remaining subjects. Family members not considered affected nonetheless contributed genotype information, when available, to increase the linkage information content among the affected men. Although such an approach may result in some loss of power, it provided a uniform approach across all participating groups, particularly important because screening of unaffected men varied across groups.
For subset analyses, pedigrees were stratified according to the following criteria: (1) average age at diagnosis within families, contrasting <65 years to 65þ years; (2) families with aggressive disease based on criteria previously described [37] . Briefly, families meeting these criteria had three or more affected individuals with PC with at least one of the following clinicopathologic characteristics: Gleason score 7 or higher, TNM stage of T3 or T4, pretreatment serum PSA 20 ng/ml, or death from PC before the age of 65. In these families, other cases not meeting any of the criteria for aggressive disease were classified as having unknown disease status; (3) families having five or more affected individuals.
Genotyping
Genome-wide SNP linkage scan genotyping was performed at the Center for Inherited Disease Research using Illumina's HumanLinkage-12 Genotyping BeadChip (http://www.cidr.jhmi.edu/human_snp.html). These chips assay 6,090 SNP markers, with an average intermarker distance of 0.58 cM across the genome and an average marker heterozygosity of 0.43 in Caucasians.
Statistical Analysis: Linkage-Analysis Methods
The computer programs Pedcheck (http://watson. hgen.pitt.edu/register/docs/pedcheck.html) and PREST (http://galton.uchicago. edu/mcpeek/software/prest/) were used for checking whether the genotypes of individuals within a pedigree are
The Prostate [41] , is noted. consistent with their specified relationships. Based on these analyses, 58 individuals were removed from further analysis.
Both parametric and nonparametric linkage analyses were performed using Merlin software [38] . The parametric LOD scores were computed using either a dominant or a recessive model, as described elsewhere [5] . LOD scores allowing for linkage heterogeneity among families (HLOD) were estimated using HOMOG [39] . Nonparametric LOD scores were calculated using the Kong and Cox exponential allele sharing model score (herein referred to as asm) [40] . Marker allele frequencies for each SNP were estimated by counting alleles across all genotyped subjects, ignoring genetic relationships. Multipoint linkage statistics were calculated at 0.5 cM intervals across the genome.
We used the r 2 option (0.1) of Merlin to remove SNPs that were in linkage disequilibrium (LD). This is necessary to reduce the positive bias of strong marker LD among flanking SNPs on linkage results, and to reduce the memory and time requirements for large pedigrees. To further fit pedigree data into the memory limits of Merlin software, trimming of family members was conducted. Un-genotyped subjects or subjects with missing phenotypes were trimmed. Trimming was performed on each pedigree to obtain a maximum bit size of 24.
To facilitate comparison of the results of this SNP scan with our previous scan using microsatellite (MS) markers, we aligned the results of these two linkage scans based on physical map positions (Build 35) of both the microsatellite markers and SNP markers.
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